181 related articles for article (PubMed ID: 29468176)
1. Inhibition of the potassium channel Kv1.3 reduces infarction and inflammation in ischemic stroke.
Chen YJ; Nguyen HM; Maezawa I; Jin LW; Wulff H
Ann Clin Transl Neurol; 2018 Feb; 5(2):147-161. PubMed ID: 29468176
[TBL] [Abstract][Full Text] [Related]
2. Kv1.3 channel blockade alleviates cerebral ischemia/reperfusion injury by reshaping M1/M2 phenotypes and compromising the activation of NLRP3 inflammasome in microglia.
Ma DC; Zhang NN; Zhang YN; Chen HS
Exp Neurol; 2020 Oct; 332():113399. PubMed ID: 32652099
[TBL] [Abstract][Full Text] [Related]
3. The potassium channel Kv1.3 as a therapeutic target for immunocytoprotection after reperfusion.
Chen YJ; Cui Y; Singh L; Wulff H
Ann Clin Transl Neurol; 2021 Oct; 8(10):2070-2082. PubMed ID: 34617690
[TBL] [Abstract][Full Text] [Related]
4. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
[TBL] [Abstract][Full Text] [Related]
5. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo.
Di Lucente J; Nguyen HM; Wulff H; Jin LW; Maezawa I
Glia; 2018 Sep; 66(9):1881-1895. PubMed ID: 30043400
[TBL] [Abstract][Full Text] [Related]
6. Immunocytoprotection after reperfusion with Kv1.3 inhibitors has an extended treatment window for ischemic stroke.
Lee RD; Chen YJ; Singh L; Nguyen HM; Wulff H
Front Pharmacol; 2023; 14():1190476. PubMed ID: 37180699
[No Abstract] [Full Text] [Related]
7. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
[TBL] [Abstract][Full Text] [Related]
8. Temporal profiling of Kv1.3 channel expression in brain mononuclear phagocytes following ischemic stroke.
Gao T; Raza SA; Ramesha S; Nwabueze NV; Tomkins AJ; Cheng L; Xiao H; Yepes M; Rangaraju S
J Neuroinflammation; 2019 Jun; 16(1):116. PubMed ID: 31153377
[TBL] [Abstract][Full Text] [Related]
9. The KCa3.1 blocker TRAM-34 reduces infarction and neurological deficit in a rat model of ischemia/reperfusion stroke.
Chen YJ; Raman G; Bodendiek S; O'Donnell ME; Wulff H
J Cereb Blood Flow Metab; 2011 Dec; 31(12):2363-74. PubMed ID: 21750563
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy.
Zhang X; Liang P; Zhang Y; Wu Y; Song Y; Wang X; Chen T; Peng B; Liu W; Yin J; Han S; He X
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499018
[TBL] [Abstract][Full Text] [Related]
11. Responses of rat and mouse primary microglia to pro- and anti-inflammatory stimuli: molecular profiles, K
Lam D; Lively S; Schlichter LC
J Neuroinflammation; 2017 Aug; 14(1):166. PubMed ID: 28830445
[TBL] [Abstract][Full Text] [Related]
12. Deficiency in the voltage-gated proton channel Hv1 increases M2 polarization of microglia and attenuates brain damage from photothrombotic ischemic stroke.
Tian DS; Li CY; Qin C; Murugan M; Wu LJ; Liu JL
J Neurochem; 2016 Oct; 139(1):96-105. PubMed ID: 27470181
[TBL] [Abstract][Full Text] [Related]
13. Antithrombin gamma attenuates macrophage/microglial activation and brain damage after transient focal cerebral ischemia in mice.
Nakano T; Nakamura Y; Irie K; Okano S; Morimoto M; Yamashita Y; Kozako T; Hayashi T; Honda SI; Matsuo K; Kamimura H; Ishikura H; Egawa T; Mishima K
Life Sci; 2020 Jul; 252():117665. PubMed ID: 32305521
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery.
Yang Y; Salayandia VM; Thompson JF; Yang LY; Estrada EY; Yang Y
J Neuroinflammation; 2015 Feb; 12():26. PubMed ID: 25889169
[TBL] [Abstract][Full Text] [Related]
15. Biophysical basis for Kv1.3 regulation of membrane potential changes induced by P2X4-mediated calcium entry in microglia.
Nguyen HM; di Lucente J; Chen YJ; Cui Y; Ibrahim RH; Pennington MW; Jin LW; Maezawa I; Wulff H
Glia; 2020 Nov; 68(11):2377-2394. PubMed ID: 32525239
[TBL] [Abstract][Full Text] [Related]
16. Differential Kv1.3, KCa3.1, and Kir2.1 expression in "classically" and "alternatively" activated microglia.
Nguyen HM; Grössinger EM; Horiuchi M; Davis KW; Jin LW; Maezawa I; Wulff H
Glia; 2017 Jan; 65(1):106-121. PubMed ID: 27696527
[TBL] [Abstract][Full Text] [Related]
17. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
18. Microglial V-set and immunoglobulin domain-containing 4 protects against ischemic stroke in mice by suppressing TLR4-regulated inflammatory response.
Lyu Q; Pang X; Zhang Z; Wei Y; Hong J; Chen H
Biochem Biophys Res Commun; 2020 Feb; 522(3):560-567. PubMed ID: 31784084
[TBL] [Abstract][Full Text] [Related]
19. Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway.
Ye Y; Jin T; Zhang X; Zeng Z; Ye B; Wang J; Zhong Y; Xiong X; Gu L
Front Cell Neurosci; 2019; 13():553. PubMed ID: 31920554
[TBL] [Abstract][Full Text] [Related]
20. Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway.
Li F; Zhao H; Han Z; Wang R; Tao Z; Fan Z; Zhang S; Li G; Chen Z; Luo Y
CNS Neurol Disord Drug Targets; 2019; 18(2):115-123. PubMed ID: 30426907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
